AnalystsAndrew CooperAndrew Cooper's Stock Forecasts
AnalystsAndrew Cooper
Analyst Ranking
Bottom 3%
#5066 out of 5192 analysts
Average Return
-5.87%
Win Rate
41%59 out of 144
Risk vs Reward
Poor
Good
Andrew Cooper's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Change Healthcare IncCHNG | +231.49% | $6.86 | $22.74 | 2020-03-17 - 2021-03-18 | Strong Buy |
Caredx IncCDNA | +191.10% | $9.66 | $28.12 | 2023-08-14 - 2024-08-14 | Buy |
Natera IncNTRA | +178.37% | $48.54 | $135.12 | 2023-11-12 - 2024-11-12 | Strong Buy |
Guardant Health IncGH | +162.52% | $40.98 | $107.58 | 2025-07-30 - 2026-02-11 | Buy |
Guardant Health IncGH | +150.94% | $42.87 | $107.58 | 2025-02-20 - 2026-02-11 | Buy |
Andrew Cooper Analyst Color
Get additional color on Andrew Cooper's coverage of popular stocks
Andrew Cooper's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Azenta IncAZTA | 2 | Buy | $45.00 | +47.78% | Maintains | 3 months ago |
Integer Holdings CorpITGR | 4 | Buy | $95.00 | +8.97% | Reiterates | 4 months ago |
Avantor IncAVTR | 15 | Buy | $16.00 | +65.98% | Maintains | 4 months ago |
Haemonetics CorpHAE | 10 | Buy | $78.00 | +35.65% | Downgrades | 6 months ago |
Guardant Health IncGH | 4 | Buy | $61.00 | -43.30% | Maintains | 6 months ago |
Revvity IncRVTY | 9 | Buy | $115.00 | +13.75% | Reiterates | 6 months ago |
Thermo Fisher Scientific IncTMO | 7 | Buy | $535.00 | +1.49% | Reiterates | 7 months ago |
Myriad Genetics IncMYGN | 5 | Buy | $10.00 | +106.19% | Reiterates | 9 months ago |
Fulgent Genetics IncFLGT | 2 | Buy | $25.00 | +8.70% | Reiterates | 9 months ago |
Hologic IncHOLX | 12 | Buy | $71.00 | -5.45% | Reiterates | 9 months ago |
Danaher CorpDHR | 7 | Buy | $275.00 | N/A | Maintains | a year ago |
Natera IncNTRA | 5 | Buy | $85.00 | N/A | Downgrades | 2 years ago |
Quidelortho CorpQDEL | 12 | Buy | $76.00 | N/A | Downgrades | 2 years ago |
Lumiradx LtdLMDXF | 10 | Buy | $0.80 | N/A | Maintains | 2 years ago |
Caredx IncCDNA | 11 | Buy | $12.00 | N/A | Upgrades | 2 years ago |
Neogenomics IncNEO | 8 | Buy | $19.00 | N/A | Maintains | 3 years ago |
Exact Sciences CorpEXAS | 6 | Buy | $60.00 | N/A | Maintains | 3 years ago |
Veracyte IncVCYT | 7 | Buy | $27.00 | N/A | Maintains | 3 years ago |
Invitae CorpNVTAQ | 6 | Hold | N/A | N/A | Downgrades | 4 years ago |
Orasure Technologies IncOSUR | 5 | Hold | N/A | N/A | Downgrades | 4 years ago |
Biora Therapeutics IncBIOR | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Covetrus IncCVET | 1 | Buy | $39.00 | N/A | Maintains | 5 years ago |
Heska CorpHSKA | 2 | Buy | $225.00 | N/A | Maintains | 5 years ago |
Change Healthcare IncCHNG | 1 | Strong Buy | $20.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.